Wellgistics Health (NASDAQ:MEDS) Cut to “Strong Sell” at Wall Street Zen

Wall Street Zen lowered shares of Wellgistics Health (NASDAQ:MEDS) to a strong sell rating in a report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Wellgistics Health in a research report on Monday, September 21st. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Wellgistics Health Stock Performance

Shares of MEDS stock opened at $3.07 on Friday. The stock’s fifty day moving average is $2.78 and its 200-day moving average is $3.85. The stock has a market capitalization of $9.82 million, a PE ratio of -0.07 and a beta of -3.51. Wellgistics Health has a 52 week low of $0.82 and a 52 week high of $73.00.

Wellgistics Health (NASDAQ:MEDS) last announced its earnings results on Monday, August 17th. The company reported ($7.13) earnings per share for the quarter. The firm had revenue of $1.78 million during the quarter.

About Wellgistics Health

Wellgistics Health, Inc is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medications. The company connects pharmaceutical manufacturers, wholesalers, pharmacies, healthcare providers and patients through technology-enabled services designed to support the movement and dispensing of medications.

Its business includes pharmaceutical distribution and related supply-chain solutions, with an emphasis on helping pharmacies and healthcare organizations source and manage prescription products.